Selasa, 28 Maret 2017

Drug to treat advanced ovarian cancer gets early FDA approval - Newsday


Newsday

Drug to treat advanced ovarian cancer gets early FDA approval
Newsday
The Food and Drug Administration has approved the use of Zejula for women with advanced ovarian cancer. It is manufactured by Massachusetts-based Tesaro, which has not released the drug's launch price. Photo Credit: Tesaro. advertisement | advertise ...
FDA Approves Niraparib for Recurrent Ovarian CancerCancer Network
BRCA Testing Has Skyrocketed, but Misses High-Risk WomenMedscape
Tesaro Wins FDA Approval for Ovarian Cancer Drug ZejulaZacks.com
Forbes -CNN -Pharmaceutical Business Review -Genetic Engineering & Biotechnology News
all 111 news articles »


from Health - Google News http://ift.tt/2oeCLnn


EmoticonEmoticon